- Home
- GREE vs CVKD Comparison
GREE vs CVKD Comparison
Compare GREE & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GREE | CVKD |
|---|---|---|
| Founded | 1937 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 19.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GREE | CVKD |
|---|---|---|
| Price | $1.33 | $7.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 144.7K | 48.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $4.91 |
| 52 Week High | $2.42 | $20.39 |
Technical Indicators
Market Signals| Indicator | GREE | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 49.24 |
| Support Level | $1.13 | $6.64 |
| Resistance Level | $1.42 | $8.87 |
| Average True Range (ATR) | 0.17 | 0.64 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 28.23 | 38.48 |
Price Performance
Historical ComparisonAbout GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.